Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5626_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
15.09.2026
Размер:
17 Мб
Скачать
☆
Index 451
dopamine (DA), 240 double maceration, 209 Dragendorff’s test, 145–146 drainage of cultivated medicinal plants, 90 Dravaka, 71 drilling method, 84
Drosera, 338 Drosera adelae, 338 Drosera aliciae, 338 Drosera binata, 338 Drosera burmannii, 338 Drosera dielsiana, 338 Drosera hilaris, 338 Drosera montana, 338 Drosera petiolaris, 338 Drosera pygmaea, 338 Drosera spatulata, 338
drought-resistant plants, 87 drug delivery systems, 12 drug design, 264 drug discovery, ethnobotanical research in, 48–49 drug-drug interaction, 423
AI and ML in, 34
drug interaction studies on botanicals and dietary
supplements, 423 with botanicals and dietary supplements, 424–428 dietary supplements and botanicals on drug,
effect of, 424 herbs and, 428 risk factors for, 424
Drugs and Cosmetics Act 1940, 88 drying, of plant material, 93 duckweed (Lemna minor), 318
Dunaliella salina, 377 Dysphania ambrosioides (Mexican tea) extract, 318
e
Ebers Papyrus, 2 Echinacea purpurea, 300
Echinacea species, authentication of, 112 echinacoside, 341 Echinodermata Phylum, 379 echinoderms, 379–380, 379 Echinoidea, 379 ecopharmacognosy, 422 ecosystem services, by marine biodiversity, 373 Ecteinascidia turbinata, 378 ecuelle, 130–131, 131 Edible Oils Packaging (Regulation) Order of 1988, 306 E-guggulsterone, 3 Ehrlich’s test, 146 eicosapentaenoic acid (EPA), 299, 318, 377 electric light scattering (ELS), 9 electric shocks, 364 electrocardiograms (ECGs), 237–238
normal ECG of rat, 237
electrofusion, 358 electrolytes, 257 electron transport chain (ETC), 260 electrophoresis, 158–159 electroporation, 364 electrospray ionization (ESI), 382 elevated plus maze test, 240 elicitation, 361 elicitors, 361 ellagic acid, 308–309 embryo culture, 359 emollients, 18 emulsion test, 150 encapsulation, 360 endangered plant species
conservation prioritization, 33 cultural and traditional knowledge, 33 data accessibility and accuracy, 32 ethical considerations in, 32 ex situ conservation and access to genetic
resources, 33 inadequate resources for research, 33 taxonomic uncertainties, 32–33
endogenous elicitors, 361 endrin, 315 energy
efficiency of enzymes, 261 molecules, 257
enfleurage, 131, 131 enhanced solvent extraction system (ESE), 133 5-enolpyruvylshikimate-3-phosphate (EPSP), 265 entomopathogenic fungi, 318 entrapment, 360 environmental management, genetic engineering
applications in, 365
Environmental Protection Agency
(EPA), 318
enzymatic method, 357 enzyme-assisted extraction, 381–382 enzyme inhibition, 252, 410 enzyme-linked immunosorbent assay (ELISA),
159, 411
enzymes, 260
in biosynthetic pathways, 261–263 catalytic mechanism, 261 functions, 260–261 role in PSMs production, 195–196, 196
ephedra (Ma Huang), 428 Ephedra sinica, 20 ephedrine, 335 epicatechin gallate, 112 epigallocatechin gallate (EGCG), 112
Eribulin, 374 Eruca sativa, 336
erythromycin, 43, 258 Escherichia coli, 362
452 Index
essential oils, 340–341
distillation, 129–130 ecuelle, 130–131, 131 enfleurage, 131, 131 expression, 130 extraction of, 129 hot maceration process/digestion, 131–132
pneumatic method, 132, 132 esterification, 278 ethanol, 257, 279 ether, 124 ethnoalgology, 46 ethnoarchaeobotany, 46 ethnobotanical survey, 43 ethnobotany, 46
ethnobotanical research in drug discovery,
48–49
ethnomedicinal plants used in folk practices,
50–56 history of, 45 origin and definition of, 44–45 subdisciplines of, 45, 46
ethnobryology, 46 ethnoecology, 46 ethnogastrology, 46 ethnohorticulture, 46 ethnolichenology, 46 ethnomedicobotany, 46 ethnomusicology, 46 ethnopharmacognosy, 46 ethnopharmacology, 46 ethnophytotaxonomy, 46 ethnopteridology, 46 ethnoveterinary, 46 ethosomes, 310 ethyl acetate, 279 ethylene, 353 ethylene diamine tetra acetic acid (EDTA), 351 ethyl esters of n–3 fatty acids, 309
Eucalyptus, 20 Euphrasia, 338 Euphrasia nemorosa, 338 Euphrasia rostkoviana, 338 Euphrasia stricta, 338
European Food Safety Authority (EFSA), 305–306 European Medicinal Agency (EMA), 435 European medicine, 47 European Union law (EU law), 297 Eurotium, 321 evaporative light-scattering detector (ELSD), 224 exogenous elicitors, 361 expression vectors, 363 ex situ conservation, 405 external calibration, 180 extracellular matrix (ECM), 302 extracted ion chromatogram (XIC), 181
extraction, 121–122, 124, 208, 380–382
accelerated solvent extraction, 215 consideration for, 208 decoction, 125 of essential oil techniques, 129–132 factor affecting, 124, 208–209 ideal properties of solvent, 122–123 with ionic liquids, 214–215 maceration, 126, 209–210 mechanism of, 124–125 methods of, 125, 209 microwave-assisted extraction, 136–138, 213 percolation, 126–129, 210–211 phytonics, 132–133 pressurized liquid extraction, 213–214, 133–134 pulsed electric field extraction, 134–135 region-wise distribution of endemic species, 122 selection of appropriate solvent for, 209 solvents for, 123–124, 123, 123 Soxhlet extraction, 211–212 supercritical fluid extraction, 138–139, 212–213 ultrasound-assisted extraction, 135–136, 214
exudate gum, 281
f
Fabaceae, 18, 19 farnesyl pyrophosphate, 267 fatty acid methyl ester (FAME), 336 fatty acids (FAs), 257, 270, 336 fatty acid synthase (FAS), 269
initiation of, 270
fatty acyl CoA
acetate mevalonate pathways for biosynthesis of,
269–271, 270
formation of, 271 Fehling’s test, 149 ferric chloride test, 147
for tannins, 148 fertilization, 84 fertilizer
of cultivated medicinal plants, 90
in plant nutrition, 87 ferulic acid (FA), 182 Fick’s law, 209 Ficus deltoidea, 339 fingerprinting techniques, 12 fish oil, 320 five-element theory, 75–76
in Tholkappiyam, 75 flame ionization detector (FID), 171, 217 flame test, 150 flash chromatography, 224–225 flavonoids, 7, 8, 23, 144, 147–148, 189, 191, 200,
258, 308, 335, 337 chemotaxonomical classes of crude drugs, 26 glycosides, 22
Index 453
flavonol aglycones, 8 flaxseed (Linum usitatissimum), 21, 22 floral scent compounds, 259 flower bud culture, 358 flowers used for medicinal purposes, 20 fluorescein diacetate (FDA), 357 fluorescent lamps, 354 Folin-Ciocalteu assay, 151, 213 Folin-Ciocalteu method, 151, 152 folk medicine
early records of, 44
ethnomedicinal plants used in folk practices, 50–56 folk taxonomies, 334 folk therapy, 1 Food, Drug, and Cosmetic Act (FDCA), 425 food allergies, 430 Food and Agricultural Organization (FAO), 306 Food and Drug Administration Modernization
Act of 1997, 306 Food Safety and Standards Authority (FSSA), 306 Food Safety and Standards Authority of India
(FSSAI), 306 forensic genetics, 403 forensic pharmacognosy, 422 Fossilia, 333 Foundation for Innovation in Medicine (FIM), 297 Fourier transform infrared spectroscopy (FTIR spectroscopy),
175, 177 foxglove (Digitalis purpurea), 7, 22, 25, 36 fractionation techniques, 215
chromatographic techniques, 216–220 counter-current chromatography, 220–221 liquid–liquid fractionation, 216 methods used for separation of phytoconstituents,
220–221 free erythrocyte protoporphyrin (FEP), 148 free radicals, 299 French lilac plant (Galega officinalis L.), 7 friable callus, 356 froth test, 147
for saponins, 148–149 fructose-induced hypertension in rats, 236–237, 237 Fruit Products Order of 1955, 306 fruits, used for medicinal purposes, 20 fucoidan, 372, 383–384 functional foods, 13, 298–299 functional genomics, 404 functional group inter-conversion, 263 fundamental metabolism, 262 furano-cembranoids, 384
g
galactose, 275–276 galantamine, 1 Galega officinalis L.. see French lilac plant
(Galega officinalis L.)
gallic acid, 265–266 gallic acid equivalent (GAE), 210 γ-amino butyric acid (GABA), 321 γ-glutamyl transpeptidase (GTP), 321 gamma-linolenic acid (GLA), 300, 310 garbling process, 92 garlic (Allium sativum), 57, 426
allicin in, 309 with antioxidant potentials, 303 phenolic compounds extraction from, 211 reduces mortality in gastric cancer, 49 supplements, 426 used for treating cancer, 56
gas chromatography (GC), 30, 144, 219, 334, 410
in detection and evaluation of adulteration, 113 in estimation of phytochemicals, 171–173 in phytochemical analysis, 157
gas chromatography-mass spectrometry (GC-MS), 3, 101,
113, 217, 408 applications in phytochemical analysis, 180–181 authentication of Ginkgo biloba extract using, 113–114 in phytochemical analysis, 158
gas chromatography with flame ionization detection
(GCFID), 336
gas-liquid chromatography (GLC), 217, 335 gastrodin, 8 gastrointestinal disorders, of medicinal plants, 57–58 gastrointestinal tract (GI tract), 424 gedunin, 199 gelatin, 279 gellan gum, 279–280, 352 gelling agent, 352 gel matrixes, entrapment in, 360 gene duplication, 401 gene-editing tools, 328 gene transfer methods, 364
direct gene transfer methods, 364 indirect gene transfer methods, 364–365
generally recognized as safe (GRAS), 310, 425 genetically modified organisms (GMOs), 403 genetic engineering, 13, 256, 347, 362, 396
applications, 365 gene transfer methods, 364–365 restriction endonuclease, 362–363 vectors as carriers of transgene, 363
genetic improvement, 406 genetic map, 402 genetic markers, 110 genetics, 403
novel technologies in biotechnology and, 403–404
genistein, 8 genome duplication, 401 genome evolution, 401 genome-wide association studies (GWAS), 404 genomics, 11 genotoxicity studies, 411
454 Index
geographical classification, of crude drugs, 26
division based on geographic origin of crude drugs, 26–27 influence of climate, soil, and environmental factors on
medicinal properties, 27
region-specific crude drugs and uses, 27–28
geraniol synthase (GES), 404
Geranium, 341 Geranium carolinianum, 341
geranyl-eranyl pyrophosphate, 267 geranyl (geranyl) diphosphate synthase (G(G) PPS), 404 geranyl pyrophosphate, 267 germplasm, 359
conservation, 405–406 Ghrita, 71 Gibberella fujikuroi, 353 gibberellins (GAs), 353 ginger
in cardiovascular diseases, 309
in gastrointestinal disorders, 57–58
Gingidia, 340 Ginkgo biloba, 11, 20, 426
adulterants identification in extracts of, 111
chromatographic and spectral fingerprints for
identification of adulterated, 112 ginkgolic acids (GAs), 111 ginseng (Panax ginseng), 20, 28, 36, 111, 308, 426–427 Glehnia littoralis, 336 gluconeogenesis, 260 glucosinolates, 26, 189, 259 glutathione peroxidase (GPx), 198, 323 glyceraldehyde-3-phosphate (G3P), 260 glycine, 334–335 glycoalkaloids, 201 glycogen synthase kinase 3 (GSK3), 379 glycolysis, 260, 262 glycosides, 3, 144, 146–147, 192–193, 258–259, 334–335, 341
in crude drugs, 21, 22 glycosylates, 22 glycosylation, 277 glycosyltransferases (GTs), 192 glycosynthases, 192 glycyrrhetic acid, 427 Glycyrrhiza glabra (liquorice), 19, 44, 411 glycyrrhizic acid, 198 glycyrrhizin, 194, 427 Golden Age of Arabic Medicine, 2 good agricultural and collection practices (GACP), 89 good agricultural practices (GAP), 88 good field collection practices (GFCP), 97 good manufacturing practice (GMP), 308, 326, 429 gradient elution, 219, 220 graft copolymerization, 278 granules, 325 gravity column chromatography, 217–218 grease spot test, 150 Greeks, medicinal plant use in, 2
green chemistry principles, 209 green extraction technology, 13 green-leaf volatiles, 189 green sea algae species, 376 green seaweeds, 376 green tea extracts, analyzing for polyphenols, 112 guanine, 256 guanosine triphosphate (GTP), 257 guar gum, 280, 280 Gum Arabic. see Acacia gum Gutika, 71 Gymnema sylvestre, 57 gypenoside XVII, 10
h
Haematococcus pluvialis, 384 Haemophilus influenzae, 321
Hager’s test, 146 hair colorants and dyes, 302 hair cosmeceuticals, 302 hair growth stimulators, 302 Halaven, 386 Halichondria okadai, 386 halichondrin B, 386 Halphen test, 150 harvesting medicinal plants, 90
plant parts and harvesting timing, 91 healthcare system, clinical pharmacognosy in, 423 hemicelluloses, 357 henna. see Lawsone hennotannic acid. see Lawsone hepatic fibrosis, 244 heptachlor, 315 herbal anti-diabetic species, 8 herbal-drug interaction, clinical support of, 435–436 herbal drugs, 143, 235, 236
adulteration of, 102–103
qualitative analysis of, 143, 144
quantitative analysis of, 144 herbal excipients, 275 herbal genomics, case studies of, 402, 402 herbal ingredients, adulterants detection in, 114–115 herbal medicinal products (HMP), 434
pharmacognosy relevance in pharmacological
research on, 3
herbal medicine, 1, 101
market potential of, 43–44
standardization using PSMs, 201–202 herbalomics, in crude drugs classification, 35 HES. see hydroxyethyl starch (HES) hesperetin, 8 Hibiscus sabdariffa, 411 hierarchical cluster analysis (HCA), 181, 339 high-efficiency particulate air filters (HEPA filters), 354 high-performance liquid chromatography (HPLC), 3, 30, 31,
101, 144, 167, 169–171, 215, 219, 334–335, 408
Index 455
analysis of phytoconstituents, 172 chromatogram, 219 in detection and evaluation of adulteration, 112–113 in phytochemical analysis, 157 of Withaferin-A standard and formulation of
Ashwagandhadi lehyam, 170
high-performance liquid chromatography with diode array
detection (HPLC-DAD), 339
high-performance thin-layer chromatography (HPTLC),
9, 169, 173–175
estimation of phytoconstituents and chromatographic
conditions, 176 high-resolution mass spectrometry (HRMS), 11 high-speed countercurrent chromatography
(HSCCC), 225 high thermal efficiency (HTE), 31–32 high throughput analysis (HTA), 32 high-value molecules (HVMs), 376 Hima, 71 histamine-induced broncho constriction in guinea pigs,
240–241 holistic patient care, 34 Holothuroidea, 379 Holothuroidea clade, 379 homeopathy system, 79
history, 79 methods of diagnosis and treatment, 80
principles of, 79–80 homeostasis, 80 Homoeopathic Pharmacopoeia of India (HPI), 97 homologous genes, 401 honey, 320 horseradish (Armoracia rusticana), 22 hot continuous percolation, 128–129 hot maceration process/digestion, 131–132, 132 hot percolation, 128 hot plate method, 249–250, 249 Huangqi Guizhi Wuwu Decoction (HGWD), 410 Human Genome Project, 256 human serum albumin, 276 humours (Uyir thathukkal), 76 hyaluronic acid (HA), 302–303, 372 hybridization, 32 Hydrastis canadensis, 435–436 hydration, 303 hydrilla (Hydrilla spp.), 318 hydro distillation, disadvantages of, 129 hydro steam distillation, 130
advantages of hydro and steam distillation over hydro
distillation, 130
disadvantages of hydro and steam distillation over water
distillation, 130 hydrochloric acid (HCl), 216 hydrodiffusion, 129 hydrogenation, 263 hydrolases, 260
hydrolysable tannins, 335, 191 hydroxy acids, 303 hydroxyethyl starch (HES), 283 hydroxyethylation, 283 7-hydroxymitragynine, 112 hydroxypropyl methylcellulose (HPMC), 278 hydroxypropyl starch (HPS), 283 hydroxypropylation, 283 Hygiene, Perfume, Cosmetics, and Sanitizing Products
Management (GHCOS), 307 hymenialdisine, 385 hyoscine, 59 Hyoscyamus Niger, 19 hyperforin, 425 hyperhydricity, 350 Hypericum perforatum. see St. John’s Wort
(Hypericum perforatum) hyphenated strategy, 225 hyphenated techniques, 113, 180–181
gas chromatography-mass spectrometry, 113–114 liquid chromatography-mass spectrometry, 114
i
iaaH gene, 365 iaaM gene, 365
Ilaj-Bil-Dawa (pharmacotherapy), 74 Ilaj-Bil-Tadbeer (regimental therapy), 74 Ilaj-Bil-Yad (surgical therapy), 74 Illicium anisatum. see Chinese star anise (Illicium anisatum) imbibition, 127 imli. see tamarind gum (Tamarindus indica L.) immobilization methods, 360 immobilized cell culture, 356 IMMU-110. see dolastatin 10 immune system support, 300 immunoenzyme test-systems, 146 immunoglobulins (Ig), 319 immunomodulatory diseases, screening models for, 247
acute-systemic anaphylaxis in rats, 247
immunomodulatory effects, of plant secondary metabolites,
197–198 India, medicinal plant use in, 2 Indian Ayurvedic system, 44 Indian dates. see tamarind gum (Tamarindus indica L.) Indian traditional medicine. see Ayurvedic medicine indirect gene transfer methods, 364–365 indirect organogenesis, 355, 355 indirect sonicator, 135, 136 individualization, 79–80 indole-3-acetic acid (IAA), 352 indole acetonitrile, 352 indole-3-butyric acid, 352 Indonesian Food and Drug Administration, 101 induced fusion, 358 inductively coupled plasma mass spectrometry (ICP MS),
30, 30
456 Index
industrially important pharmaceutical aids, 275
Acacia gum, 275, 275 agar-agar, 275–276, 276 albumin, 276 alginates, 276–277 anthocyanidins, 277 cellulose, 277, 277 chitosan, 278 cochineal, 278–279 curcumin, 279 gelatin, 279 gellan gum, 279–280 guar gum, 280 inulin, 281 Karaya gum, 280 Lawsone, 281 locust bean gum, 281–282 pectins, 282, 282 starch, 282–283
tragacanth gum, 280–281, 281
xanthan gum, 283–284 inflammation, 310, 58–59 inflammatory marker assays, 411 inflammatory polyarthritis, 242 infrared spectroscopy (IR spectroscopy), 4, 29, 144, 336
in phytochemical analysis, 158 ingestible skincare. see nutricosmetics inhibitory concentrations 50 (IC50), 251 inhibitory concentrations 90 (IC90), 251 inorganic nutrients, 349
macronutrients, 350 insect growth regulators (IGRs), 88 insect pheromones, 318 Insecta, 333 insect-based anti-allergens, 319 insect-based biopesticides, 318 Insecticides Act, The, 1968, 326 in situ conservation, 405 integrated pest management programs (IPM programs), 316 Intellectual Property Rights, 28 intermediates, 262–263 internal standardization, 180 International Code of Botanical Nomenclature (ICBN), 4 International Code of Nomenclature for Algae, Fungi, and
Plants (ICN), 18
International Pharmaceutical Excipients Councils
(IPEC), 273 inter-simple sequence repeat (ISSR), 12, 399 intertidal zones, 372 inulin, 281
in vitro cell cultures, 195 in vitro models, 251
culture methods, 251 enzyme inhibition and receptor binding assay, 252 germplasm conservation, 359–360
isolated organs, 251 tissue culture, 349
in vitro toxicity assays, 411 in vivo models, 235
analgesic activity, screening models for, 249–250 anti-inflammatory activity, screening models for, 248–249 antipyretic activity, screening models for, 250 cancer, screening models for, 246–247 cardiovascular system diseases, screening models for,
236–238 dermal diseases, screening models for, 250–251 digestive system diseases, screening models for, 243–245 immunomodulatory diseases, screening models for, 247 metabolic diseases, screening models for, 245–246 musculoskeletal diseases, screening models for, 242–243 nervous system diseases, screening models for, 238–240 ophthalmic diseases, screening models for, 247–248 respiratory system diseases, screening models for, 240–241 urinary system diseases, screening models for, 241–242
in vivo toxicity studies, 411 iodine (I), 350–351
test, 149 value for fixed oils and waxes, 155
iodine value test, 150 ion-exchange chromatography, 219 ionic liquids (ILs), 124, 214
extraction with, 214–215
ionotropic gelation, 276 iposide, 3 iridoid glycosides, 22 irinotecan, 3
Iris, 337 Iris bungei, 338 Iris lactea, 338 Iris tenuifolia, 338
iron (Fe), 350–351 irrigation
affecting medicinal plant cultivation, 86–87 of cultivated medicinal plants, 90
Isatis tinctoria, 404 isocorynantheidine, 112 isoflavones, 309 isolated organs, 251 isolation of intermediates, 261 isoleucine, 268–269 isomerases, 260 isomerization, 263 isopentenyladenine (iP), 353 isopentenyl diphosphate (IPP), 263–264, 266, 270 isopimpinellin, 337 isoprenaline (ISO), 238
isoprenaline-induced myocardial infraction, 238
isoprenoids, 267, 268
intermediates, 270, 271
isoquinoline alkaloids, 337 isorhamnetin, 338
Index 457
isoschaftoside, 339 isothiocyanates, 309
glycosides, 22 isotope dilution analysis, 180 isotopes, 259 isovitexin, 339
j
Japanese flower shikimi, 265 Japanese Kampo Medicine, 28 Japanese star anise. see Japanese flower shikimi
k
Kaempferia galangal (ginger), 303 kaempferol, 8 kaempferol-3-O-glucoside, 339 Kalka, 71 kaolin clay, 318 Kapha dosha, 68–69 kapham, 76 Karaya gum, 280 Kava Kava (Piper methysticum), 436 Kefir, 300 Keller-Killiani test, 146–147 Kerria lacca. see Kwatha Churna 2-keto-3-deoxy-7-phosphoglucoheptonic acid, 265 keto-enol tautomerism, 263 ketones, 263 Kickxia aegyptiaca (L.), 4 kimchi, 300 kinetic maceration, 126 kinetin, 352–353 Kingdom Plantae, 18 Kjeldahl method, protein determination by, 154 Kovacs test, 150 Kratom (Mitragyna speciosa), 112
alkaloids’ quantification in, 112–113 Krebs cycle. see citric acid cycle Kwatha Churna, 71
l
lac insect (Kerria lacca), 25 lactate dehydrogenase (LDH), 322
Lactobacillus, 320 Lactobacillus rhamnosus GG, 320
ladybugs, 88 Laminaria hyperborea, 276 Lanolin, 301 laser ablation inductively coupled plasma mass spectrometry
(LA-ICP-MS), 30 latex, 259 Law of Minimum Dose, 79 Law of Similar, 79 Law of Single Remedy, 79 Lawsone, 281 Lawsonia inermis, 281
leaching process, 92–93 lead acetate test, 148 leaf culture, 358 leaves used for medicinal purposes, 20 left border (LB), 365 left coronary artery ligation method, 237 Lemna minor. see duckweed (Lemna minor) Lepa, 72 Leptosphaeria oraemaris, 383 letrozole-induced polycystic ovarian syndrome in female rats,
245–246, 245 leucine, 268–269 L-glutamate, 257 Liber Magnae Collectionis Simplicum Alimentorum Et
Medicamentorum (Baitar), 2 licorice (Glycyrrhiza glabra), 20, 427 lifestyle disorders, 298 ligases, 260 lignans, 23, 192, 200, 341–342
in crude drugs, 22 Lignarenone B, 379 Limniris, 337–338 linear regression analysis, 181 lipid, 149–150, 256, 257
biosynthesis, 260 lipoic acid, 309 lipophilic allergens, 430 liposomes, 310 5-lipoxygenase (5-LOX), 248 lipoxygenases (LO), 201 liquid chromatography (LC), 113, 219, 334 liquid chromatography–electrospray ionization–tandem mass
spectrometry (LC–ESI–MS/MS), 171
liquid chromatography-mass spectrometry (LC-MS), 3, 112,
144, 408 applications in phytochemical analysis, 180–181 authentication of Ginkgo biloba extract using, 114 in phytochemical analysis, 158
liquid chromatography-nuclear magnetic resonance-mass
spectroscopy (LC-NMR-MS), 180 for comprehensive structural elucidation, 181
liquid–liquid chromatography (LLC), 217 liquid–liquid fractionation, 216 liquorice (Glycyrrhiza glabra), 22
Lissoclinum patella, 383 Lithospermum erythrorhizon, 322
L-lysine, 257 locust bean gum, 281–282 Lonchocarpus utilis, 322 London Pharmacopeia in 1618, 395 loperamide, 7 lovastatin, 43 low-density lipoprotein (LDL-C), 309 low-methoxy pectin, 282 Lowry method, protein determination by, 154–155 Lowry protein assay, 150
458 Index
lurbinectedin, 386 lutein, 309 lyases, 260 lycopene, 308, 376
Lyngbya lagerhaimanii, 375 Lyngbya majuscule, 375 Lysimachia baviensis, 338
lysine, 335
m
maceration, 124, 126, 127, 209–210 machine learning (ML)
in crude drugs classification, 35
role in crude drugs, 34 macroalgae, 376, 382–383 Macrocystis pyrifera, 276 macromorphological authentication, 5 macromorphological characters of plant, 5 macronutrients, 350 macrophage chemostatic protein (MCP-1), 200 macroscopic identification, of plant, 4 Madagascar periwinkle plant (Catharanthus roseus (L.)),
7, 212 magnesium (Mg), 350 magnetic resonance imaging (MRI), 159 Maillard method, 424 malaria treatment, Artemisia annua for, 35 Malas, 69 malondialdehyde (MDA), 191, 241, 323 malonyl-CoA, 262, 264, 270 malvidin, 277 manganese (Mn), 350 mangiferin, 322 mangrove forests, 372 manures
of cultivated medicinal plants, 90 in plant nutrition, 87
marine algae
bioactive compounds and applications, 376–378 diversity of marine macroalgae, 375–376
and medicinal potential, 375 marine bacteria, 383 marine-based anti-allergens, 319 marine-based biopesticides, 318 marine biodiversity, ecosystem services provided by, 373 marine compounds, 372
collecting and processing of, 380 marine-derived compounds
anticancer properties of marine compounds, 382–384
neuroprotective and neuropharmacological effects, 384–385
pharmacological activities of, 382 marine-derived hydrogels, 372 marine ecosystems, 372–373 marine environments
biodiversity in, 372–373
microbial diversity in, 374
marine fungi, 383 marine invertebrates, 378
bioactive compounds from, 380 echinoderms, 379–380 molluscs, 379 sponges, 378
marine macroalgae, 376
diversity of, 375–376
marine microorganisms, 318
aplidin, 386 bioactive compounds from, 373 bryostatin-1, 386 dolastatin 10, 386 halaven, 386 lurbinectedin, 386 preclinical and clinical studies of, 385–386 squalamine, 386
marine natural products (MNPs), 378
advancements in marine natural product research, 388
marine organisms, 371
adaptations and survival strategies, 373 for bioactive compounds, 371 drug discovery, importance in, 371–372
marine pharmacognosy, 371
analytical tools and technologies, 382 bioactive compounds, exploring marine organisms for, 371 bioactive compounds from marine microorganisms,
373–375
drug discovery, importance of marine organism in,
371–372
extraction process and characterization techniques,
380–382 future prospects, 388 marine algae and medicinal potential, 375–378 marine ecosystems and biodiversity, 372–373 marine invertebrates, 378–380 marketed marine drug product, 386, 387 pharmacological activities of marine-derived compounds,
382–385 preclinical and clinical studies of marine microorganisms,
385–386
marine pigments, 319 marine plants, 382
macroalgae, 382–383 microalgae, 383
marine polysaccharides, 319 marine proteins, 319 marinosomes, 310 marker-assisted selection (MAS), 406 marketed marine drug product, 386, 387 market trends and consumer preferences, 311 Marrubium vulgare, 57 mass propagation, 405 mass spectrometry (MS), 11, 30, 31, 144, 179, 224, 264, 167,
334, 336, 371, 374, 382, 407, 431 adulterants detection in herbal ingredients, 114–115
Index 459
MS-based plant metabolomics study, 409 in phytochemical analysis, 158 quality control measures for phytochemicals, 180 quantitative analysis for phytochemicals, 179–180
structural elucidation of phytochemicals by, 179 mass spectrometry imaging (MSI), 158 mass-to-charge ratio (m/z ratio), 382, 408 matrix-assisted laser desorption/ionization (MALDI), 382 Mayer’s test, 146 Meat Food Products Order of 1973, 306 mechanical fusion, 358 mechanical method, protoplast isolation, 357 mechanical shearing method, 362 medicinal herbs
establishment of fingerprint profiles, 109–110
evaluation of, 107
microscopic analysis, 108–109
molecular genetic basis for economic features of, 401–402
morphological analysis, 108
multiple marker-based fingerprint profiles for adulterants
detection, 110–111 organoleptic analysis, 109 qualitative and quantitative of phytochemical for
contaminants detection, 109 taxonomic deciding adulteration of medicinal plants,
107–108
medicinal plants, 43–44
adulteration in, 106–107 anticancer activity, 49–57 antidiabetic activity, 57 anti-inflammatory activity, 58–59 antiviral activity, 58 biological activity of, 49 biotechnology, 347 cultivation, 83–85 ethnomedicinal plants used in folk practices, 50–56 gastrointestinal disorders, 57–58 genetic engineering, 362–364 good agricultural practice, 88–91 good collection practices for, 91–92 growing conditions for plants, 94–96 metabolomics in medicinal plant research, 407–408 molecular biosynthesis and metabolomics of, 407 molecular genetics and genomics of, 399–404 permissible levels of contaminants under GAP and GFCP,
98–99 plant tissue culture, 347–362 processing of, 92–93 respiratory disorders, 58 sample record for cultivated medicinal plants, 94 selection, 89 storage and packaging, 93–94 VCSMPP in Indian scenario, 97–99
Melia azedarach L., 4 meristematic cells, 347 Mesopotamia region, medicinal plant use in, 2
MetaboAnalyst, 408 metabolic diseases, screening models for, 245
letrozole-induced polycystic ovarian syndrome in female
rats, 245–246, 245
streptozotocin-induced diabetes in rats, 245 metabolic engineering techniques, 13 metabolic intermediates, 257 metabolic profiling method, 396 metabolism, 259 metabolite profiling techniques, 11 metabolomics, 11, 182, 396, 407
in crude drugs classification, 35
techniques and analytical tools, 408–410 metal-chelating proteins, 299 Metarhizium anisopliae, 318 MetExplore, 408 Metformin, 7 7-methoxylated flavonoids, 338 methoxylation, 282 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine
(MPTP), 384 mevalonate, 262, 264 MI. see myocardial infarction (MI) microalgae, 375, 383 microbial assays, 410 microbial diversity, in marine environment, 374 microbial interactions, 13 Micrococcus luteus, 310 microinjection, 364 micronutrients, 350–351 microorganism-based anti-allergens, 320–321 microorganism-based biopesticides, 318–319 microprojectile bombardment/gene gun, 364 micropropagation, 355 microscopy, in detection and evaluation of herbal
adulteration, 111 microwave-aided extraction, 171 microwave-assisted extraction (MAE), 121, 136–138, 209, 213,
381–382 microwave-assisted hydrodistillation, 138 microwave cavity, 137 microwave generator, 137 mid-infrared spectroscopy (MIR), 8 milk thistle (Silybum marianum), 7, 427 Millon’s test, 150 mind–body connection in beauty, 305 Minerae, 333 mineral-based crude drugs, 25 minerals, 299 Ministry of Health, 305, 307 mitochondrial function assays, 411 mitogen-activated protein kinases (MAPK), 248, 322 mitragynine, 112 mitraphylline, 112 Mizaj, 73 mobilizing genes (mob genes), 363
460 Index
modern analytical techniques, 167, 168–169
advantages and challenges of, 31–32 in classification, 29 DNA barcoding, 31
use of advanced analytical methods, 29–31 modern extraction methods, 125 modern pharmacognosy, 3 modern pharmacology, 33 modified legal’s test, 147 modified maceration, 126, 209 moisturization, 303 moisturizers, 303 molecular biology techniques, 256, 395
DNA extraction, polymerase chain reaction, sequencing,
and cloning, 397 molecular markers, barcodes, and databases, 398–399, 399 in pharmacognosy, 396, 398–399 significance, 397–398
molecular biosynthesis and metabolomics
applications and benefits of metabolomics, 408 medicinal plant research, importance and application of
metabolomics in, 407–408 of medicinal plants, 407, 407 metabolomics techniques and analytical tools, 408–410
molecular docking studies, 411 molecular genetics and genomics of medicinal plants, 399
genetics, 403–404 genome duplication, 401 genome evolution, 401 herbal genomics, case studies of, 402, 402 medicinal herbs, molecular genetic basis for economic
features of, 401–402 transcriptome analysis, 402
molecular imaging techniques, 182 molecular markers, barcodes, and databases, 398–399, 399 molecular pharmacognosy, 395, 422. see also clinical
pharmacognosy bioassays, 410 current trends in, 396 history and evolution of, 395–396
in vitro toxicity assays, 411 in vivo toxicity studies, 411
molecular biology techniques in pharmacognosy, 396–399 molecular biosynthesis and metabolomics of medicinal
plants, 407–410 molecular genetics and genomics of medicinal plants,
399–404 molecular pharmacology and toxicology of medicinal
plants, 410–413 pharmacodynamics, pharmacokinetics, and clinical
trials, 411 phytochemical analysis, 410 plant-derived drugs, mechanism of action, efficacy, and
toxicity of, 412–413 PTC of medicinal plants, 404–407 receptor binding studies, 410–411
risk assessment, 412 safety pharmacological studies, 412 scope and objectives, 396
and toxicology of medicinal plants, 410 Molisch’s test, 149, 150 molluscs, 379, 379 molybdenum (Mo), 350–351 Momordica charantia, 57 Monocots, 18 Monocotyledons, 18 monoterpenes, 335 Montana, 19 Moraxella catarrhalis, 321 morphine, 1, 309 morphological classification, of plants, 19
division based on plant parts used for medicinal purposes,
20–21
examination of macroscopic and microscopic
characteristics, 21 Morris water maze test, 239 mouse tail model for psoriasis, 250–251 multilocus banding patterns, 12 multimode MAE, 137, 137 multi-omics integration, in crude drugs classification, 35 multiple maceration, 209 multiple marker-based fingerprint profiles, for adulterants
detection, 110–111 multitargeted approaches, 11–12 multivariate analysis techniques, 181–182 multivariate chromatographic fingerprint, 182 Murashige and Skoog medium (MS medium), 352 musculoskeletal diseases, screening models for, 242
collagen type-II-induced arthritis in rats, 242–243
ovariectomy-induced osteoporosis in female rats, 243 muskgrass (Chara spp.), 318 mustard (Sinapis alba), 26 mycosporine-like amino acids (MAAs), 377 myocardial infarction (MI), 237 myricetin, 8 myristicin, 201 MZmine, 408
n
Nagoya Protocol, 28, 380 naked plant cell, 357 n-alkyl glycoside derivatives, 341 Nannochloropsis oculata, 377 NaOH test, 148 Nardostachys grandiflora, 340 naringenin, 8, 198 naringin, 198 National Institute of Standards and Technology Mass Spectral
database (NIST-MS database), 179 National Medical Products Administration (NMPA), 307 National Medicinal Plant Board (NMPB), 97 Native American healing, 101